Full-Time

Technical Lead

Application Development

Posted on 1/15/2025

Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

10,001+ employees

Develops medicines for serious diseases

Biotechnology
Healthcare

Compensation Overview

$141.8k - $231.4kAnnually

Expert

Tarrytown, NY, USA

Hybrid position requiring in-office presence.

Category
Full-Stack Engineering
Web Development
Software Engineering
Required Skills
Agile
JavaScript
React.js
MySQL
Postgres
TypeScript
AWS
Development Operations (DevOps)
Requirements
  • Bachelor's Degree or higher
  • At least 10 years of relevant IT experience
  • 4+ years of building applications in the cloud
  • JavaScript development
  • Expert knowledge of web application and cloud-based architecture patterns
  • Hands-on experience with React
  • Hands-on experience with Typescript
  • Hands-on experience with AWS services such as Lambda and RDS
  • Hands-on experience with MySQL/PostgresSQL
Responsibilities
  • Developing solutions across the entire stack from web applications to cloud based APIs and services using JavaScript and AWS services
  • Engaging with internal clients to understand use cases and gather feedback
  • Managing technical work and timelines
  • Prioritizing and completing multiple initiatives in an agile environment
  • Coordinating cloud based (AWS) infrastructure with DevOps team
  • Keeping informed of new and emerging technologies to incorporate into our technical stack
  • Ensuring alignment to architecture guidelines and frameworks related to logging, authentication, security, error recovery, etc.
Desired Qualifications
  • Enjoy managing production enterprise applications and developing reusable libraries/code modules
  • Have an eye for detail and pride yourself on the quality of your work
  • Thrive in a fast-paced environment
  • Work on current problems while thinking of future solutions
Regeneron Pharmaceuticals

Regeneron Pharmaceuticals

View

Regeneron Pharmaceuticals develops medicines aimed at treating serious diseases such as cancer, eye diseases, and allergic conditions. The company uses its own technologies and extensive research to create new therapies, often collaborating with academic institutions and other pharmaceutical companies to enhance its development efforts. Unlike many competitors, Regeneron focuses on both research and commercialization, generating revenue through the sale of its approved medicines and licensing its technologies. The goal of Regeneron is to improve patient outcomes by providing effective treatments and ensuring that its products meet high safety and efficacy standards.

Company Stage

IPO

Total Funding

$684M

Headquarters

Town of Greenburgh, New York

Founded

1988

Simplify Jobs

Simplify's Take

What believers are saying

  • Regeneron's investment in Truveta enhances its genomic data capabilities for personalized medicine.
  • The Oxular acquisition expands Regeneron's portfolio in retinal disorder treatments.
  • Dupixent's FDA review for CSU could open a new revenue stream for Regeneron.

What critics are saying

  • Class action lawsuits may lead to financial liabilities and reputational damage.
  • Investment in Truveta may not yield expected financial returns.
  • Competition from AstraZeneca and Amgen could impact Regeneron's market share.

What makes Regeneron Pharmaceuticals unique

  • Regeneron leverages proprietary technologies for innovative treatments in serious diseases.
  • The company collaborates with academic and research institutions to enhance R&D efforts.
  • Regeneron's strategic partnerships enable shared costs and profits in new treatment development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Wellness Program

Paid Vacation

Equity Awards

Annual Bonuses

Flexible Work Hours